# Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research

> **NCT07403071** · — · NOT_YET_RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 200 (estimated)

## Conditions studied

- Multiple Myeloma
- Peripheral Neuropathy Due to Chemotherapy

## Interventions

- **DIETARY_SUPPLEMENT:** Fish Oil (Containing Omega-3 Acids)

## Key facts

- **NCT ID:** NCT07403071
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07403071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07403071, "Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07403071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*